Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”

Age-specific numbers and rates of PUD globally in 2021 for both sexes. by Wende Hao (10315597)

Subjects:

Sex and age differences in smoking-attributable RA burden in 2021. by Kaibin Lin (9911049)

Subjects:

Joinpoint regression analysis of the sex-specific ASRs for PUD globally from 1990 to 2021. by Wende Hao (10315597)

Subjects:

The change of disease burden of CRD by sex in Fujian, 1990-2021. by Yanrong Yin (14292683)

Subjects:

Predictions of Age-Standardized Rate of burden caused by fire, heat and hot substances for different sexes in 2030 based on the Bayesian Age-Period-Cohort model. by Shi Huang (125861)

Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China. by Yu Fu (16582)

Subjects:

Incidence, death and DALYs of TB, by age and sex in 2021. by Xue Li (285380)

Subjects:

Age patterns by sex of the total number and age-specific DALYs rate. by Xinyue Qi (9637055)

Subjects:

Age patterns by sex of the total number and age-specific death rates in 2021. by Xinyue Qi (9637055)

Subjects:

Predicted trends in Age-standardized rates of PUD for both sexes globally over the next 19 years (2022-2040). by Wende Hao (10315597)

Subjects:

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”

Trends in the all-age numbers and age-standardized incidence, prevalence, mortality and DALYs rates of PUD by sex from 1990 to 2021. by Wende Hao (10315597)

Subjects:

Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China. by Yu Fu (16582)

Subjects:

Numbers of deaths, mortality rates, and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Sex differences and percentage change trends in smoking-attributable RA burden from 1990 to 2021. by Kaibin Lin (9911049)

Subjects:

Decomposition analysis of changes in hepatitis B virus (HBV) burden by region (China vs. Global), sex, and disease stage, 1990–2021. by Xinyue Qi (9637055)

Subjects:

Decomposition analysis of changes in hepatitis B virus (HBV) burden by region (China vs. Global), sex, and disease stage, 1990 to 2021 (in Thousands). by Xinyue Qi (9637055)

Subjects:

Period-specific relative risks (RRs) for CRC burden by sex in East Asian countries, the United States, and globally, based on the age-period-cohort model. by Yuanyi Cao (22394797)

Subjects:

Age-specific relative risks (RRs) for CRC burden by sex in East Asian countries, the United States, and globally, based on the age-period-cohort model. by Yuanyi Cao (22394797)

Subjects: